Earnings History Data for Clearside Biomedical, Inc. (CLSD) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Clearside Biomedical, Inc.

Clearside Biomedical, Inc. is a biopharmaceutical company is engaged in developing first-in-class drug therapies to treat blinding diseases of the eye using Clearside proprietary suprachoroidal space(TM) microinjector. Its products include CLS-1001 for the treatment of macular edema associated with non-infectious uveitis; CLS-1003 for the treatment of macular edema associated with retinal vein occlusion; and CLS-1002 program for the treatment of wet age-related macular degeneration. Clearside Biomedical, Inc. is headquartered in Alpharetta, Georgia.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
12-11-2024	AH		CLSD	Clearside Biomedical, Inc.	85.21	-0.10	-0.14	-0.15	Clearside Biomedical GAAP EPS of -$0.10 beats by $0.02, revenue of $1.03M beats by $0.91M [11/12/2024 4:36 PM]	1.07	-0.04 (-3.15%)	1.14	0.03 (2.54%)	0.88 - 2.12	263,601	300,000	3,778
Clearside Biomedical GAAP EPS of -$0.10 beats by $0.02, revenue of $1.03M beats by $0.91M [11/12/2024 4:36 PM] Clearside Biomedical Inc (CLSD) Q3 2024 Earnings Report Preview: What to Look For [Nov-11-24 07:23AM] Clearside Biomedical Announces Third Quarter 2024 Financial Results and Provides Corporate Update [2024-11-12 04:05PM]
12-08-2024	AH		CLSD	Clearside Biomedical, Inc.	79.22	-0.10	-0.14	-0.15	Clearside Biomedical GAAP EPS of -$0.10 beats by $0.04, revenue of $0.09M misses by $0.04M [8/12/2024 4:35 PM]	1.07	0.0 (0.00%)	1.07	0.0 (0.00%)	0.65 - 2.12	129,587	210,000	2,378
Clearside Biomedical GAAP EPS of -$0.10 beats by $0.04, revenue of $0.09M misses by $0.04M [8/12/2024 4:35 PM]
09-05-2024	AH		CLSD	Clearside Biomedical, Inc.	95.64	-0.17	-0.14	-0.15	Clearside Biomedical GAAP EPS of -$0.17 misses by $0.03, revenue of $0.23M misses by $0.45M [5/9/2024 4:52 PM]	1.26	-0.09 (-6.67%)	1.35	0.0 (0.00%)	0.65 - 2.12	273,348	140,000	3,058
Clearside Biomedical GAAP EPS of -$0.17 misses by $0.03, revenue of $0.23M misses by $0.45M [5/9/2024 4:52 PM]
12-03-2024	AH		CLSD	Clearside Biomedical, Inc.	104.22	-0.08	-0.10	-0.16	Clearside Biomedical GAAP EPS of -$0.08 beats by $0.01, revenue of $6.35M beats by $2.11M [3/12/2024 4:06 PM]	1.66	0.02 (1.22%)	1.69	0.05 (3.06%)	0.65 - 2.12	791,027	860,000	9,807
Clearside Biomedical GAAP EPS of -$0.08 beats by $0.01, revenue of $6.35M beats by $2.11M [3/12/2024 4:06 PM]
13-11-2023	AH		CLSD	Clearside Biomedical, Inc.	51.65	-0.15	-0.16	-0.13	Clearside Biomedical GAAP EPS of -$0.15 in-line, revenue of $0.86M beats by $0.73M [11/13/2023 4:10 PM]	0.9523	-0.02 (-1.82%)	1.01	0.04 (4.12%)	0.65 - 1.85	117,903	280,000	260
Clearside Biomedical GAAP EPS of -$0.15 in-line, revenue of $0.86M beats by $0.73M [11/13/2023 4:10 PM]
14-08-2023	AH		CLSD	Clearside Biomedical, Inc.	67.22	-0.15	-0.14	-0.13	Clearside Biomedical GAAP EPS of -$0.15 misses by $0.01, revenue of $1.02M beats by $0.95M [8/14/2023 4:20 PM]	1.00	-0.06 (-5.66%)	1.03	-0.03 (-2.83%)	0.90 - 1.85	470,674	70,000	31,975
Clearside Biomedical GAAP EPS of -$0.15 misses by $0.01, revenue of $1.02M beats by $0.95M [8/14/2023 4:20 PM]
11-05-2023	PM	7:15 AM ET (May 11)	CLSD	Clearside Biomedical, Inc.	66.27	-0.15	-0.14	-0.13	Clearside Biomedical GAAP EPS of -$0.15 misses by $0.01, revenue of $0.04M misses by $0.1M [5/11/2023 7:12 AM]	1.08	-0.08 (-6.90%)	1.10	-0.06 (-5.17%)	0.90 - 1.86	119,645	140,000	9,098
Clearside Biomedical GAAP EPS of -$0.15 misses by $0.01, revenue of $0.04M misses by $0.1M [5/11/2023 7:12 AM]
09-03-2023	AH	After the close (Mar 9)	CLSD	Clearside Biomedical, Inc.	80.05	-0.16	-0.13	0.31	Clearside Biomedical GAAP EPS of -$0.16 misses by $0.04, revenue of $0.3M beats by $0.2M [3/9/2023 4:34 PM]	1.06	-0.13 (-10.92%)	1.15	-0.04 (-3.24%)	0.98 - 2.85	479,781	120,000	109
Clearside Biomedical GAAP EPS of -$0.16 misses by $0.04, revenue of $0.3M beats by $0.2M [3/9/2023 4:34 PM]
09-11-2022	PM	7:05 AM ET (Nov 9)	CLSD	Clearside Biomedical, Inc.	88.48	-0.13	0.04	-0.08	Clearside Biomedical GAAP EPS of -$0.13 beats by $0.01, revenue of $0.26M misses by $6.26M [11/9/2022 7:26 AM]	1.28	-0.12 (-8.57%)	1.42	0.02 (1.43%)	1.00 - 5.22	970,769	150,000	127,271
Clearside Biomedical GAAP EPS of -$0.13 beats by $0.01, revenue of $0.26M misses by $6.26M [11/9/2022 7:26 AM] Clearside stock rises as CLS-AX shows promise in early-stage study in eye disorder [11/9/2022 7:47 AM] Clearside Biomedical upgraded at Stifel on next-generation wet-AMD candidate [11/9/2022 2:05 PM]
09-08-2022	PM	7:05 AM ET (Aug 9)	CLSD	Clearside Biomedical, Inc.	98.05	-0.13	-0.13	-0.11	Clearside Biomedical GAAP EPS of -$0.13 beats by $0.01, revenue of $0.38M beats by $0.08M [8/9/2022 7:15 AM]	1.62	-0.02 (-1.22%)	1.78	0.14 (8.54%)	1.26 - 7.73	299,618	110,000	8,505
Clearside Biomedical Q2 2022 Earnings Preview [8/8/2022 1:37 PM] Clearside Biomedical GAAP EPS of -$0.13 beats by $0.01, revenue of $0.38M beats by $0.08M [8/9/2022 7:15 AM] Clearside Biomedical Announces Second Quarter 2022 Financial Results and Provides Corporate Update [Aug-09-22 07:05AM] Clearside Biomedical Enters into Non-Dilutive Financing Agreement with HealthCare Royalty Partners for up to $65 Million [Aug-08-22 04:30PM] ANI Pharmaceuticals (ANIP) Tops Q2 Earnings and Revenue Estimates [Aug-08-22 08:05AM]
11-05-2022	AH	4:05 PM ET (May 11)	CLSD	Clearside Biomedical, Inc.	87.82	-0.13	-0.03	-0.13	Clearside Biomedical GAAP EPS of -$0.13 misses by $0.10, revenue of $0.35M misses by $5.85M [5/11/2022 4:12 PM]	1.35	-0.10 (-6.80%)	1.40	-0.05 (-3.45%)	1.30 - 7.73	267,389	250,000	2,264
Clearside Biomedical GAAP EPS of -$0.13 misses by $0.10, revenue of $0.35M misses by $5.85M [5/11/2022 4:12 PM] Clearside Biomedical Announces First Quarter 2022 Financial Results and Provides Corporate Update [May-11-22 04:05PM] Clearside Biomedical, Inc. (CLSD) Reports Q1 Loss, Misses Revenue Estimates [May-11-22 05:25PM]
10-03-2022	AH	4:05 PM ET (Mar 10)	CLSD	Clearside Biomedical, Inc.	85.32	0.31	0.09	-0.14	Clearside Biomedical GAAP EPS of $0.31 beats by $0.16, revenue of $25.7M beats by $8.26M [3/10/2022 4:16 PM]	1.93	0.58 (42.97%)	1.85	0.50 (37.04%)	1.31 - 7.73	22,676,799	630,000	2,351,157
Clearside Biomedical GAAP EPS of $0.31 beats by $0.16, revenue of $25.7M beats by $8.26M [3/10/2022 4:16 PM] Clearside Biomedical gains as milestones payments drive strong Q4 beat [3/10/2022 4:41 PM] Clearside Biomedical Announces Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update [Mar-10-22 04:05PM] Clearside Biomedical, Inc. (CLSD) Q4 Earnings and Revenues Beat Estimates [Mar-10-22 05:25PM]
10-11-2021	AH	4:05 PM ET (Nov 10)	CLSD	Clearside Biomedical, Inc.	313.46	-0.08	-0.09	-0.05	Clearside Biomedical EPS misses by $0.01, beats on revenue [11/10/2021 4:35 PM]	4.87	-0.08 (-1.62%)	5.04	0.09 (1.82%)	1.43 - 7.73	441,914	310,000	608
Clearside Biomedical EPS misses by $0.01, beats on revenue [11/10/2021 4:35 PM] Clearside Biomedical Announces Third Quarter 2021 Financial Results and Provides Corporate Update [Nov-10-21 04:05PM] Clearside Biomedical, Inc. (CLSD) Reports Q3 Loss, Misses Revenue Estimates [Nov-10-21 05:45PM] Clearside Biomedical to Participate in Upcoming Investor Events in November and December 2021 [Nov-11-21 07:05AM]
10-08-2021	AH	4:05 PM ET (Aug 10)	CLSD	Clearside Biomedical, Inc.	298.83	-0.11	-0.12	-0.13	Clearside Biomedical EPS beats by $0.01, beats on revenue [8/10/2021 4:20 PM]	5.37	0.43 (8.72%)	5.00	0.06 (1.21%)	1.25 - 7.29	1,161,471	370,000	628
Clearside Biomedical EPS beats by $0.01, beats on revenue [8/10/2021 4:20 PM] Clearside Biomedical Announces Second Quarter 2021 Financial Results and Provides Corporate Update [Aug-10-21 04:05PM] Clearside Biomedical, Inc. (CLSD) Reports Q2 Loss, Tops Revenue Estimates [Aug-10-21 05:45PM]
17-05-2021	AH	4:05 PM ET (May 17)	CLSD	Clearside Biomedical, Inc.	156.61	-0.13	-0.08	-0.07	Clearside Biomedical EPS misses by $0.03 [5/17/2021 4:15 PM]	2.40	0.03 (1.27%)	2.41	0.04 (1.69%)	1.25 - 4.53	237,744	130,000	102
Clearside Biomedical EPS misses by $0.03 [5/17/2021 4:15 PM] Clearside Biomedical, Inc. to Host Earnings Call [May-17-21 02:45PM] Clearside Biomedical Announces First Quarter 2021 Financial Results and Provides Corporate Update [May-17-21 04:05PM]
10-03-2021	AH	4:05 PM ET (Mar 10)	CLSD	Clearside Biomedical, Inc.	180.63	-0.14	-0.13	-0.07	Clearside Biomedical EPS misses by $0.03, misses on revenue [3/10/2021 4:20 PM]	3.17	-0.35 (-9.94%)	3.34	-0.18 (-5.11%)	1.10 - 4.53	317,413	404,909	5,234
Clearside Biomedical EPS misses by $0.03, misses on revenue [3/10/2021 4:20 PM] The Daily Biotech Pulse: MediciNova Bags BARDA Contract, Lilly's COVID-19 Antibody Cocktail Data, Bluebird Bio Refutes Blood Cancer Link [Mar-10-21 07:25AM] Clearside Biomedical, Inc. to Host Earnings Call [Mar-10-21 01:30PM] Clearside Biomedical Announces Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update [Mar-10-21 04:05PM] Clearside Biomedical, Inc. (CLSD) Reports Q4 Loss, Lags Revenue Estimates [Mar-10-21 05:35PM]
10-11-2020	AH	4:05 PM ET (Nov 10)	CLSD	Clearside Biomedical, Inc.	63.95	-0.05	-0.14	-0.17	Clearside Biomedical EPS beats by $0.06, beats on revenue [11/10/2020 4:22 PM]	1.47	-0.06 (-3.92%)	1.63	0.10 (6.54%)	0.96 - 4.13	256,848	118,350	17,296

10-08-2020	AH	4:05 PM ET (Aug 10)	CLSD	Clearside Biomedical, Inc.	97.22	-0.13	-0.13	-0.15	Clearside Biomedical EPS misses by $0.06, misses on revenue [8/10/2020 4:29 PM]	1.78	-0.01 (-0.41%)	1.89	0.10 (5.59%)	0.56 - 4.13	843,930	326,535	179,572